This page includes the latest FDA filings for Foundation Medicine Inc 150 Second Streetcambridge Ma 02141 Pma Numberp190032 Supplement Numbers007 Date Received08 29 2022 Decision Date09 21 2022 Product Code Pqp Advisory Committee Pathology Supplement Typespecial Immediate Track Supplement Reason Labeling Change Indications Instructions Shelf Life Tradename Expedited Review Granted No. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
Device Company | Device | Date |
|---|---|---|
| Foundation Medicine Inc.150 Second Streetcambridge, MA 02141 PMA NumberP190032 Supplement NumberS007 Date Received08/29/2022 Decision Date09/21/2022 Product Code PQP Advisory Committee Pathology Supplement Typespecial (immediate Track) Supplement Reason Labeling Change - Indications/instructions/shelf Life/tradename Expedited Review Granted? No | FoundationOne Liquid CDx (F1 Liquid CDx) | 2022-09-21 |